The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
Recent News
Microsoft Outage Takes Outlook and Teams Offline
November 25, 2024
Paul Caponigro, Photographer in Love with Nature, Dies at 91
November 25, 2024
Biden Pardons Turkeys for the Last Time as President
November 25, 2024
Can Wall Street Billionaires Deliver on Trump’s Blue-Collar Promise?
November 25, 2024
U.S. Says Google Is an Ad Tech Monopolist, in Closing Arguments
November 25, 2024
Judge Allows San Jose State Volleyball Player to Compete
November 25, 2024
Steve Witkoff, Trump’s Middle East Envoy, Has Ties to Oil-Rich Nations
November 25, 2024